10-Q: OneMedNet Reports Q3 Loss, Strategic Shift to iRWD Amid Liquidity Concerns

OneMedNet Corporation reported a net loss of $0.7 million for Q3 2025, narrowing from the prior year, driven by a strategic pivot to web imaging revenue and significant debt restructurings, while facing substantial doubt about its ability to continue as a going concern.

Summary

• Net loss for the three months ended September 30, 2025, was $0.7 million, a significant improvement from a $2.1 million loss in the prior year period.
• For the nine months ended September 30, 2025, the company reported a net income of $0.3 million, a substantial turnaround from a $7.8 million net loss in the same period of 2024, primarily due to gains from troubled debt restructurings.
• Total revenue for Q3 2025 increased by 25% to $0.2 million, driven by a 343% increase in web imaging (iRWD) revenue to $0.2 million.
• Subscription revenue (BEAM) decreased by 100% in Q3 2025 to $0, following the decommissioning of the BEAM platform on May 31, 2025.
• Overall revenue for the nine months ended September 30, 2025, decreased by 24% to $0.5 million, largely due to the planned discontinuation of BEAM.
• Gross margin remained negative, worsening by 164% to $(0.2) million in Q3 2025 and by 162% to $(0.7) million for the nine months ended September 30, 2025.
• Operating expenses decreased by 11% to $2.0 million in Q3 2025 and by 11% to $5.9 million for the nine months ended September 30, 2025.
• Cash and cash equivalents stood at $0.1 million as of September 30, 2025, down from $0.2 million at December 31, 2024.
• Investment in crypto assets (Bitcoin) significantly decreased to $0.6 million as of September 30, 2025, from $2.8 million at December 31, 2024.
• Total current liabilities dramatically decreased to $5.0 million as of September 30, 2025, from $19.2 million at December 31, 2024, largely due to debt conversions and restructurings.
• The company's accumulated deficit was $101.2 million as of September 30, 2025.
• Management has identified material weaknesses in internal controls over financial reporting, including user access/segregation of duties and lack of formalized control environment.
• A lawsuit was filed by ARC Group Limited on November 6, 2025, alleging breach of contract and seeking reinstatement of cancelled shares or damages.
• The company raised approximately $2.5 million in net proceeds from a June 2025 private placement and $1.7 million from related party subscription agreements during the nine months ended September 30, 2025.
• Subsequent to the quarter end, in October 2025, the company sold 535,880 shares to Yorkville under a Standby Equity Purchase Agreement (SEPA) for approximately $1.6 million gross proceeds.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the explicit 'going concern' warning, recurring operating losses, and reliance on non-recurring gains for net income. While there's a positive strategic shift and some capital raises, the fundamental financial instability and internal control weaknesses overshadow these positives. Significant dilution from recent capital raises also weighs negatively on existing shareholders.

Positives

• Net loss significantly narrowed for the three months ended September 30, 2025, to $0.7 million from $2.1 million in the prior year.
• Achieved a net income of $0.3 million for the nine months ended September 30, 2025, a substantial improvement from a $7.8 million net loss in the comparable prior year period.
• Web imaging (iRWD) revenue increased by 343% to $0.2 million in Q3 2025 and by 109% to $0.4 million for the nine months ended September 30, 2025, demonstrating successful strategic pivot.
• Operating expenses decreased by 11% for both the three and nine months ended September 30, 2025, indicating cost management efforts.
• Successfully restructured and converted significant debt obligations, including PIPE Notes, loan extensions, and shareholder loans, reducing total current liabilities from $19.2 million to $5.0 million.
• Settled deferred underwriter fees of $3.3 million for a $0.5 million cash payment, resulting in a $2.8 million gain on troubled debt restructuring.
• Secured additional capital through a June 2025 private placement ($2.5 million net proceeds) and related party subscription agreements ($1.7 million net proceeds).
• The registration statement for the Standby Equity Purchase Agreement (SEPA) with Yorkville was declared effective on July 24, 2025, enabling future equity sales.

Negatives

• The company has incurred recurring operating losses since its inception and had an accumulated deficit of $101.2 million as of September 30, 2025.
• Cash and Bitcoin balance of $0.7 million as of September 30, 2025, is not adequate to fund operations for at least the next twelve months, raising substantial doubt about the company's ability to continue as a going concern.
• Total revenue for the nine months ended September 30, 2025, decreased by 24% due to the decommissioning of the BEAM platform.
• Gross margin remained negative and worsened by 164% in Q3 2025 and 162% for the nine months ended September 30, 2025, primarily due to the BEAM transition and higher iRWD costs.
• Net cash used in operating activities increased to $5.8 million for the nine months ended September 30, 2025, from $5.0 million in the prior year, indicating increased cash burn.
• Investment in crypto assets (Bitcoin) decreased significantly from $2.8 million to $0.6 million, potentially reducing treasury flexibility.
• The net income reported for the nine months ended September 30, 2025, was heavily influenced by non-recurring gains from troubled debt restructurings ($5.6 million) and changes in fair value of PIPE Notes ($1.2 million income), rather than core operational profitability.
• The company recognized a loss on extinguishment of debt of $41 thousand in Q3 2025 related to an amended promissory note.

Risks

• Ability to continue as a going concern is in substantial doubt due to recurring operating losses and inadequate cash/Bitcoin balances to fund operations for the next 12 months.
• Inability to raise substantial additional capital in sufficient amounts or on acceptable terms to fund operations and business plan.
• Risks inherent with investing in Bitcoin, including its extreme volatility, lack of central regulation, and potential for loss if exchanges shut down.
• Uncertainty regarding the long-term value of crypto assets and the impact of future regulatory actions or policies on their demand and price.
• Inability to reverse the recent decline in overall revenue and resume growing revenue, despite iRWD segment growth.
• Reliance on third-party suppliers for operations.
• Competition from existing and new products or services.
• Challenges in expanding the organization to accommodate potential growth and retaining/attracting key personnel.
• Potential for substantial costs from lawsuits to enforce or protect intellectual property rights, or from claims of infringement by third parties.
• Changes in demand for products and services due to geopolitical and/or macroeconomic conditions.
• Material weaknesses in internal controls over financial reporting, including user access/segregation of duties, lack of formalized control environment, errors in non-routine transactions, and lack of record keeping, which could adversely affect the ability to record, process, summarize, and report financial information reliably.

Future Outlook

The company's continuation as a going concern is dependent upon its ability to raise additional working capital through equity or debt offerings and ultimately attain profitable operations. Management plans to pursue such financing to fulfill operating and capital requirements for at least 12 months from the issuance date of the financial statements. There is no assurance that such financing will be secured in a timely manner or on favorable terms, and existing stockholders may experience dilution if equity securities are issued.

Management Comments

• "To continue and expand its operations, the Company will be required to, and management plans to, raise additional working capital through equity or debt offerings and ultimately hopes to attain profitable operations to fulfill its operating and capital requirements for at least 12 months from the date of the issuance of the condensed consolidated financial statements."
• "The Company intends to vigorously defend itself against the claims in the ARC complaint in excess of these amounts [recorded liabilities]. The Company is also assessing whether there are any counterclaims available to it arising out of self-dealing transactions between ARC and the sponsor."
• "Over time, as we continue to grow and add accounting staff, we expect to continue to enhance our internal control structure, including appropriate segregation of duties."
• "Management has begun taking remediation steps to address the material weakness, including the hiring of a full-time controller in July 2025 and adding additional review procedures over our financial records."

Industry Context

OneMedNet operates in the healthcare software industry, focusing on digital medical image management, exchange, and sharing. The strategic shift from the BEAM platform to an enhanced focus on iRWD (Real World Data) sales aligns with a growing industry trend towards leveraging real-world evidence for pharmaceutical, device manufacturing, and AI markets. While the company is streamlining its offerings, the overall market for digital health solutions and data analytics continues to expand, presenting both opportunities and intense competition. The company's investment in Bitcoin as a treasury strategy is an outlier in the traditional healthcare software sector, introducing additional market volatility and regulatory risks not typically associated with its core business.

Comparison to Industry Standards

• NA

Management Changes

Corporate Governance

Legal Proceedings

• On November 6, 2025, ARC Group Limited and ARC Opportunity Fund Limited (ARC) filed a complaint against the company and certain officers in the District Court of Minnesota, Fourth Judicial District.
• The ARC complaint alleges breach of certain financial advisory contracts, specifically claiming improper cancellation of shares of Common Stock issued to ARC and failure to pay certain cash amounts when due.
• ARC seeks specific performance to reinstate the cancelled shares or, alternatively, compensatory damages (plus prejudgment interest) and punitive damages.
• The company has recorded a forward contract to issue 1,240,644 shares of Common Stock to ARC for success fees and $0.4 million in aggregate cash liabilities payable to ARC.
• The company intends to vigorously defend itself against claims exceeding these recorded amounts and is assessing counterclaims arising from alleged self-dealing transactions between ARC and the sponsor (an affiliate of ARC).
• No additional liability has been recorded for the ARC complaint as the company does not believe any incremental loss is probable or reasonably estimable.

Related Party Transactions

• PIPE Notes: $1.0 million of the $1.5 million total proceeds from PIPE Notes were with related party investors. In June 2025, 972,326 shares of Common Stock were issued to these related party investors upon conversion.
• PIPE Warrants: 63,829 of the total 95,744 PIPE Warrants were issued to related party investors.
• Shareholder Loans: Received gross proceeds of $1.6 million (convertible) and $0.7 million (non-convertible) from two related party investors between 2023 and 2024. In June 2025, these loans were converted into an aggregate of 3,166,476 shares of Common Stock.
• Loan Extensions: Assumed existing loan extensions to related parties. In June 2025, two related party investors converted $2.6 million of outstanding balances into 3,650,248 shares of Common Stock.
• Subscription Agreements: Issued 3,438,537 shares of Common Stock for gross proceeds of $1.7 million pursuant to subscription agreements with two related party investors in June and August 2025. This includes 581,395 shares issued to Dr. Thomas Kosasa, a director, for $0.5 million.

Stakeholder Impact

• Shareholders: Face significant dilution from recent and planned equity raises, including conversions of debt to equity and private placements. The 'going concern' warning poses a substantial risk to investment value. The ARC lawsuit could further impact share value and corporate resources.
• Employees: The strategic shift to iRWD and decommissioning of BEAM may lead to changes in roles or workforce adjustments. Increased headcount in sales and marketing for iRWD suggests growth opportunities in that area. Weak internal controls could impact employee morale and operational efficiency.
• Customers: The decommissioning of the BEAM platform impacts existing BEAM customers, while the enhanced focus on iRWD aims to improve service and offerings for iRWD clients.
• Creditors: Debt restructurings and conversions have significantly reduced current liabilities, potentially improving the company's short-term debt profile, though some creditors received equity or reduced payments.
• Regulatory Authorities: The identified material weaknesses in internal controls and the ongoing legal proceedings will likely draw scrutiny from regulatory bodies like the SEC.

Next Steps

• Raise additional working capital through equity or debt offerings to fund operations and capital requirements for at least 12 months.
• Continue remediation steps to address material weaknesses in internal controls over financial reporting, including enhancing segregation of duties and review procedures.
• Vigorously defend against the legal complaint filed by ARC Group Limited and assess potential counterclaims for self-dealing transactions.

Key Dates

Recommendation

The company explicitly states 'substantial doubt about the Company’s ability to continue as a going concern' due to recurring operating losses and insufficient liquidity. While the company reported a net income for the nine months, this was primarily driven by non-recurring gains from troubled debt restructurings and fair value adjustments, not sustainable operational profitability. Overall revenue is declining, and gross margins remain negative. The significant dilution from recent capital raises and the ongoing material weaknesses in internal controls further compound the risks. The legal dispute with ARC adds another layer of uncertainty and potential financial strain. For a seasoned investor, these fundamental issues, coupled with the high-risk Bitcoin treasury strategy, indicate severe financial distress and a high probability of further value erosion.

Keywords

OneMedNet, ONMD, SEC Filing, 10-Q, Financial Results, Healthcare Software, Medical Imaging, Real World Data, iRWD, BEAM Platform, Liquidity, Going Concern, Debt Restructuring, Capital Raise, Bitcoin Investment, Internal Controls, Legal Proceedings, Shareholder Loans, Private Placement, Warrants, Nasdaq